Follow the CPH Group AG stock price and the full directors' dealings record of the company, a listed equity based in Switzerland. Shares are quoted on CH CH, under the authority of SIX SER. Operating in the Chemicals & Materials sector, CPH Group AG has logged 54 reports. Market capitalisation: €344.1m. The latest transaction was reported on 22 May 2026 (Purchase). Among the most active insiders: Anonymous (Non-executive member of the board of directors). All data is accessible without an account.
54
Insider Decl.
0
Thresholds
€994,476
38 ops.
Buy Volume
€666,026
16 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate CPH Group AG Buy (bullish), based on 4 analysts. Average price target: CHF 89.73.
23Σ signal
Buys €994,476€666,026 Sells
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 5,118 of 26,102 companies
67.1
score / 100
Value
69
Quality
65
FCF yld3.8%
Earn yld6.9%
EV/EBITDA8.0x
ROE11%
Gross mgn48%
Net mgn7.0%
Debt/EBITDA1.1x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 22 May 2026
Declarations54 total
●
Anonymous (a non-executive member of the board of directors)
a non-executive member of the board of directors·Executives·(filed)
1,730 shares@ CHF 62.06270.028% mcap10.0% of flowSIX:T1Q4O000B5
Ideal exit: 19 Jan 2027 (T+270)
25 of 54 declarations
About CPH Group AG
CPH Group AG is a Swiss industrial group listed on the SIX Swiss Exchange (SMI/SPI) under ticker CPHN.SW. Headquartered in Perlen, Lucerne canton, Switzerland, the company completed a major strategic reset in 2024 when it spun off its paper business and the associated Perlen site real estate into a separate vehicle, Perlen Industrieholding AG. Since then, CPH Group AG has been a more focused specialty industrial company centered on two business divisions: Chemistry, operated through Zeochem, and Packaging, operated through Perlen Packaging. This sharper structure has improved transparency for investors and highlights the group’s concentration on higher-value niche markets. ([reports.cph.ch](https://reports.cph.ch/24/en/lagebericht?utm_source=openai))
The group’s industrial roots go back more than 200 years, making it one of Switzerland’s long-established manufacturing names. Over time, it evolved from a broader chemical-and-paper conglomerate into a more globally oriented specialty platform. The CPH name was adopted in 2024, replacing the former CPH Chemie + Papier Holding AG brand. Management continues to emphasize international expansion as a core pillar of strategy, supported by manufacturing and commercial operations across Europe, the United States, China, Brazil, India, Bosnia and Herzegovina, Israel and Hungary. This footprint is strategically important because it brings production closer to customers, reduces supply-chain risk and supports local market development. ([cph.ch](https://cph.ch/cph-group/history/?utm_source=openai))
Zeochem serves demanding end markets with specialty chemistry products including molecular sieves, silica gels, zeolites and deuterated products. Its portfolio is used in industrial, scientific and energy-related applications, and the division operates a multi-site global manufacturing network. Perlen Packaging supplies pharmaceutical packaging solutions, especially high-barrier blister films for solid-dose medicines. The division has built a strong reputation in PVdC-coated high-barrier films, a technically demanding niche where performance, regulatory compliance and customer qualification matter more than scale alone. In that sense, CPH’s competitive position is built on specialization rather than commodity volume. ([cph.ch](https://cph.ch/wp-content/uploads/2025/03/Geschaeftsbericht_gesamt_2024_en.pdf))
From a market perspective, CPH is positioned as a niche specialty manufacturer with Swiss industrial quality, global reach and exposure to resilient end markets such as healthcare, pharmaceuticals and advanced materials. Management has stated that the group aims to hold or achieve leadership positions in its specific market segments. Recent milestones include the 2024 spin-off of the paper division, continued internationalization, and further acquisitions in both Chemistry and Packaging that broaden capabilities and strengthen geographic coverage. These developments support a more focused investment case for shareholders seeking exposure to Swiss industrial names listed on the SIX Swiss Exchange (SMI/SPI). ([reports.cph.ch](https://reports.cph.ch/24/en/lagebericht?utm_source=openai))